Canopy Growth Corporation
CGC • NASDAQ
Canopy Growth Corporation is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Luc Mongeau, with a market cap of $377.7M.
CEOLuc Mongeau
Market Cap$377.7M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees1.0K
Websitecanopygrowth.com
Next Earnings
Upcoming earnings announcement for Canopy Growth Corporation
Date
Friday, May 29, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2026
EPS Estimate
-$0.06
Revenue Estimate
$53.3M
Earnings History
Past 12 earnings reports for Canopy Growth Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Q3 2026 | -$0.13Est: -$0.03 | -333.3% | $64.8MEst: $50.6M | +28.1% |  10-Q |
| Nov 7, 2025 | Q2 2026 | -$0.01Est: -$0.11 | +90.9% | $48.4MEst: $52.3M | -7.5% | 10-Q |
| Aug 8, 2025 | Q1 2026 | -$0.16Est: -$0.15 | -6.7% | $64.1MEst: $47.9M | +33.8% | 10-Q |
| May 30, 2025 | Q4 2025 | -$1.01Est: -$0.10 | -910.0% | $45.7MEst: $49.9M | -8.4% | 10-K |
| Feb 7, 2025 | Q3 2025 | -$0.79Est: -$0.48 | -64.6% | $61.7MEst: $47.7M | +29.3% | 10-Q |
| Nov 8, 2024 | Q2 2025 | -$1.11Est: -$0.27 | -311.1% | $46.2MEst: $47.1M | -2.0% | 10-Q |
| Aug 9, 2024 | Q1 2025 | -$1.19Est: -$0.35 | -240.0% | $48.4MEst: $53.8M | -10.1% | 10-Q |
| May 30, 2024 | Q4 2024 | -$0.79Est: -$0.33 | -139.4% | $54.0MEst: $53.1M | +1.8% | 10-K |
| Feb 9, 2024 | Q3 2024 | -$2.04Est: -$0.37 | -451.4% | $66.2MEst: $55.4M | +19.4% | 10-Q |
| Nov 9, 2023 | Q2 2024 | -$1.60Est: -$1.30 | -23.1% | $51.9MEst: $68.1M | -23.8% | — |
| Aug 9, 2023 | Q1 2024 | -$0.50Est: -$1.30 | +61.5% | $90.2MEst: $68.0M | +32.6% | 10-Q |
| Jun 22, 2023 | Q4 2023 | -$2.40Est: -$1.50 | -60.0% | $72.6MEst: $73.2M | -0.8% | — |